The results showed that SETDB1 expression was significantly related to clinicopathological stages of tumors, including PAAD (p = 0.0444), LIHC (p = 0.0132), KICH (p = 0.00939), and testicular germ cell tumors (TGCT) (p = 0.0468) (Figure 6(a)). Here, SETDB1 is linked to pancreatic adenocarcinoma.